Regulations.gov document
Zhao, X., Liu, Q., Cao, S., Pang, J., Zhang, H., Feng, T., Deng, Y., Yao, J., & Li, H…
Supporting & Related Material · FDA-2025-P-3956 · posted Sep 23, 2025
Key facts
| Document ID | FDA-2025-P-3956-0176 |
|---|---|
| Title | Zhao, X., Liu, Q., Cao, S., Pang, J., Zhang, H., Feng, T., Deng, Y., Yao, J., & Li, H. (2018). A meta-analysis of selective serotonin reuptake inhibitors (SSRIs) use during prenatal depression and risk of low birth weight and small for gestational age. Journal of Affective Disorders, 241, 563–570. https://doi.org/10.1016/j.jad.2018.08.061 |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2025-P-3956 |
| Posted | Sep 23, 2025 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: